EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report)’s stock price traded down 16.9% on Thursday . The stock traded as low as $0.15 and last traded at $0.15. 21,718 shares traded hands during mid-day trading, an increase of 447% from the average session volume of 3,967 shares. The stock had previously closed at $0.18.
EOM Pharmaceuticals Stock Down 16.9 %
The business’s 50 day moving average price is $0.29 and its 200-day moving average price is $0.28.
About EOM Pharmaceuticals
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
See Also
- Five stocks we like better than EOM Pharmaceuticals
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Value Stocks Too Small For Buffett’s Portfolio
- ETF Screener: Uses and Step-by-Step Guide
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What is Insider Trading? What You Can Learn from Insider Trading
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
